Sign In
Buy SDGR
$14.93
-0.0100 (-0.0669%)
At Close: Jun 03, 2026
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:00am, Wednesday, 19'th May 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today reported Inducement Grants under Nasdaq Listing Rule 5635(c)(4).
Schrödinger: Under The Radar And Brimming With Potential
08:34am, Tuesday, 18'th May 2021
Schrödinger: Under The Radar And Brimming With Potential
Schrödinger, Inc.'s (SDGR) CEO Ramy Farid on Q1 2021 Results - Earnings Call Transcript
12:54pm, Tuesday, 11'th May 2021
Schrödinger, Inc.'s (SDGR) CEO Ramy Farid on Q1 2021 Results - Earnings Call Transcript
Schrodinger, Inc. (SDGR) Reports Break-Even Earnings for Q1
09:01am, Tuesday, 11'th May 2021
Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of 100.00% and 10.02%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Schrodinger Q1 Earnings
07:16am, Tuesday, 11'th May 2021
Shares of Schrodinger (NASDAQ:SDGR) decreased 1.4% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 100.00% over the past year to $0.00, whic
Schrödinger Reports First Quarter 2021 Financial Results and Provides Company Update
07:01am, Tuesday, 11'th May 2021
NEW YORK--(BUSINESS WIRE)---- $SDGR #earnings--Schrödinger reported financial results for the first quarter of 2021 and provided a company update.
Schrodinger (SDGR) to Report Q1 Earnings: What's in Store?
09:46am, Monday, 10'th May 2021
Schrodinger's (SDGR) first-quarter results are likely to reflect benefits from collaborations.
Schrödinger to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
08:01am, Tuesday, 04'th May 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will participate in the Bank of America Securities 2021 Virtual Healthcare Conference.
Schrodinger - Continued Volatility, Continued Promise
03:08am, Monday, 03'rd May 2021
Schrodinger has done well as a company and very well as a stock since the company went public last year. Valuation multiples have expanded a great deal as investors price in the near unlimited potenti
Schrödinger to Host Conference Call to Discuss First Quarter 2021 Financial Results
08:01am, Tuesday, 27'th Apr 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will report first quarter 2021 financial results on May 11, 2021.
NEW YORK--(BUSINESS WIRE)---- $SDGR #AACR21--Schrödinger presented new preclinical data from its CDC7 inhibitor program during AACR 21 Annual Virtual Meeting.
Schrödinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery
08:01am, Friday, 09'th Apr 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that the company will participate in the BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery.
Schrödinger to Host Webcast in Conjunction with Presentation of Preclinical Data for Its CDC7 Program at Virtual AACR Annual Meeting
08:01am, Tuesday, 30'th Mar 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger will host a webcast to review the preclinical data being presented at the AACR Annual Meeting.
NEW YORK--(BUSINESS WIRE)--Schrödinger will participate in the virtual Credit Suisse 2021 Healthcare Innovators Series on March 23, 2021.
Is There Any Hope Left for Schrodinger Stock?
06:40am, Saturday, 13'th Mar 2021
This drug discovery company's stock just took a major hit.
